Proton Therapy Fails Survival Test in Liver Cancer Trial

· 8 source(s)

A major trial found proton therapy did not improve overall survival for advanced hepatocellular carcinoma, while separate studies linked digital media risks, plant-based food support, and pulse intake to health outcomes.

Initial results of the NRG Oncology NRG-GI003 clinical trial show that proton therapy did not improve overall survival compared with photon therapy in patients with advanced hepatocellular carcinoma. Medical Xpress reports that the trial crossed a futility boundary at a planned interim analysis and was released for reporting. Proton therapy also did not improve the secondary endpoints, according to the same source.

In other research, Medical Xpress reports that brain tissue removed during surgery has revealed a potential way to curb inflammation linked to Alzheimer's disease and traumatic brain injury. The study suggests an existing drug can work in brain cells to target inflammatory conditions.

A three-paper series in The Lancet, authored by 13 global experts, argues that digital media health risks warrant global action to protect young people. Medical Xpress reports the authors call for coordinated governance of digital systems, with the health and online safety of children and young people made an immediate global policy priority.

Health records from 68 adults link plant-based grocery support to lower blood pressure and weight, according to Medical Xpress. The findings suggest that providing nutritious foods can improve management of chronic metabolic diseases such as type 2 diabetes and hypertension, though most studies of "Food Is Medicine" programs have only examined short-term impacts.

Separately, research from two William & Mary students found that higher intake of pulses—edible seeds from legumes such as dry beans, chickpeas, lentils and dry peas—is linked to lower risk of heart disease and diabetes. Medical Xpress reports the analysis indicates that increasing pulse intake could significantly lower the risk of heart attack.

On the policy front, STAT reports that President Trump announced $90 payments for seniors' Medicare Part B premiums ahead of the November 3 midterm elections. The promise of more payments to voters comes just before the elections, according to STAT.

Knowledge graph

Drag to pan · pinch or the + / − buttons to zoom · swipe up or down to scroll the page.

Read the graph as a list
  • NRG-GI003 trial tested Proton therapy
  • NRG-GI003 trial compared with Photon therapy
  • NRG-GI003 trial involved Hepatocellular carcinoma
  • Proton therapy did not improve survival in Hepatocellular carcinoma
  • Alzheimer's disease reported by The Lancet
  • The Lancet published series on Digital media
  • Digital media linked to Plant-based grocery support
  • Plant-based grocery support lowered Blood pressure
  • Pulses reduced risk of Heart disease
  • Pulses reduced risk of Diabetes
  • Donald Trump announced payments for Medicare Part B
  • Medicare Part B ahead of Midterm elections
  • Medical Xpress reported NRG-GI003 trial
  • Medical Xpress reported Alzheimer's disease
  • Medical Xpress reported The Lancet
  • Medical Xpress reported Plant-based grocery support
  • Medical Xpress reported Pulses

16 entities · 17 relations. event product organisation figure person policy

Do this with your own documents

This post is one article and one graph built from 8 sources. Hand BisMaps your own pile — the notes, the brief, the report — and get the same thing back, with a quote behind every point. Free includes a run on your own files.

Get the daily digest

One email a day: the day written up and drawn as a graph, with the sources behind it. No spam, unsubscribe any time.

Sources

Written by an AI model from the sources listed above, then published without edits. It writes up what those sources reported and adds nothing of its own — for the full story, follow the links. Model: deepseek-chat.

More health